Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1993 Jun;50(6):491–496. doi: 10.1136/oem.50.6.491

Health, employment, and financial outcomes in workers with occupational asthma.

P F Gannon 1, D C Weir 1, A S Robertson 1, P S Burge 1
PMCID: PMC1035473  PMID: 8329312

Abstract

OBJECTIVE--To study the health, employment, and financial outcome of occupational asthma. DESIGN--A follow study of workers with confirmed occupational asthma. SETTING--A specialist occupational lung disease clinic. SUBJECTS--All workers had a diagnosis of occupational asthma made at least one year earlier. Diagnosis was confirmed by serial peak expiratory flow measurement, specific bronchial provocation testing, or specific immunology. MAIN OUTCOME MEASURES--Respiratory symptoms, medication, pulmonary function, employment state, and financial position. RESULTS--112 of a total of 140 eligible workers were followed up. 32% of patients remained exposed to the causative agent. These workers had more symptoms at follow up than those removed and a greater number were taking inhaled steroids. Continued exposure was also associated with a fall in % predicted forced expiratory volume in one second (FEV1) of 3% compared with that at presentation. Their median loss of annual income due to occupational asthma was 35%. Those removed from exposure were worse off financially (median loss 54% of annual income), had fewer respiratory symptoms than the group who remained exposed, and their % predicted FEV1 had improved by 4.6%. Statutory compensation and that obtained by common law suits did not match the loss of earnings due to the development of occupational asthma. Of the workers removed from exposure, those who no longer complained of breathlessness had been diagnosed significantly earlier after the onset of their first symptom (48 v 66 months, p = 0.001) and had a significantly higher FEV1 at presentation (90% v 73% predicted, p = 0.008) compared with those who were still breathless. They had developed symptoms earlier after first exposure (48 v 66 months, p > 0.05) and had been removed from exposure sooner (eight v 12 months, p > 0.05). CONCLUSION--Removal from exposure after diagnosis of occupational asthma is beneficial in terms of symptoms and lung function, but is associated with a loss of income. Early diagnosis is important for symptomatic improvement after removal from exposure. Inadequate compensation may contribute to the workers' decision to remain exposed after diagnosis.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. G. Long-term effects on the health of men engaged in the manufacture of tolylene di-isocyanate. Br J Ind Med. 1975 Feb;32(1):72–78. doi: 10.1136/oem.32.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker D. B., Gann P. H., Brooks S. M., Gallagher J., Bernstein I. L. Cross-sectional study of platinum salts sensitization among precious metals refinery workers. Am J Ind Med. 1990;18(6):653–664. doi: 10.1002/ajim.4700180604. [DOI] [PubMed] [Google Scholar]
  3. Burge P. S. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Thorax. 1982 May;37(5):348–353. doi: 10.1136/thx.37.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chan-Yeung M., Lam S., Koener S. Clinical features and natural history of occupational asthma due to western red cedar (Thuja plicata). Am J Med. 1982 Mar;72(3):411–415. doi: 10.1016/0002-9343(82)90497-1. [DOI] [PubMed] [Google Scholar]
  5. Chan-Yeung M., MacLean L., Paggiaro P. L. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol. 1987 May;79(5):792–796. doi: 10.1016/0091-6749(87)90212-0. [DOI] [PubMed] [Google Scholar]
  6. Davies G. E., Thompson A. V., Niewola Z., Burrows G. E., Teasdale E. L., Bird D. J., Phillips D. A. Allergy to laboratory animals: a retrospective and a prospective study. Br J Ind Med. 1983 Nov;40(4):442–449. doi: 10.1136/oem.40.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hudson P., Cartier A., Pineau L., Lafrance M., St-Aubin J. J., Dubois J. Y., Malo J. L. Follow-up of occupational asthma caused by crab and various agents. J Allergy Clin Immunol. 1985 Nov;76(5):682–688. doi: 10.1016/0091-6749(85)90671-2. [DOI] [PubMed] [Google Scholar]
  8. Lozewicz S., Assoufi B. K., Hawkins R., Taylor A. J. Outcome of asthma induced by isocyanates. Br J Dis Chest. 1987 Jan;81(1):14–22. doi: 10.1016/0007-0971(87)90103-3. [DOI] [PubMed] [Google Scholar]
  9. Malo J. L., Cartier A., Ghezzo H., Lafrance M., McCants M., Lehrer S. B. Patterns of improvement in spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis. 1988 Oct;138(4):807–812. doi: 10.1164/ajrccm/138.4.807. [DOI] [PubMed] [Google Scholar]
  10. Paggiaro P. L., Bacci E., Dente F. L., Talini D., Giuntini C. Prognosis of occupational asthma induced by isocyanates. Bull Eur Physiopathol Respir. 1987 Nov-Dec;23(6):565–569. [PubMed] [Google Scholar]
  11. Paggiaro P. L., Loi A. M., Rossi O., Ferrante B., Pardi F., Roselli M. G., Baschieri L. Follow-up study of patients with respiratory disease due to toluene diisocyanate (TDI). Clin Allergy. 1984 Sep;14(5):463–469. doi: 10.1111/j.1365-2222.1984.tb02230.x. [DOI] [PubMed] [Google Scholar]
  12. Rosenberg N., Garnier R., Rousselin X., Mertz R., Gervais P. Clinical and socio-professional fate of isocyanate-induced asthma. Clin Allergy. 1987 Jan;17(1):55–61. doi: 10.1111/j.1365-2222.1987.tb02319.x. [DOI] [PubMed] [Google Scholar]
  13. Venables K. M., Davison A. G., Newman Taylor A. J. Consequences of occupational asthma. Respir Med. 1989 Sep;83(5):437–440. doi: 10.1016/s0954-6111(89)80078-2. [DOI] [PubMed] [Google Scholar]
  14. Yassi A. Health and socioeconomic consequences of occupational respiratory allergies: a pilot study using workers' compensation data. Am J Ind Med. 1988;14(3):291–298. doi: 10.1002/ajim.4700140307. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES